Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: Investigating Stem-like CD4 T Cells in Tumors: A New Perspective on Antitumor Immunity

  • By

  • Jiaxiang Xu

  • Yunchao Yang

  • Jun Zhang

  • Yue Zhang

  • September 14, 2026

Share

Original Source(s)

Correction: Stem-like CD4 T cells in tumors: an emerging framework for antitumor immunity

  • by Jiaxiang Xu, Yunchao Yang, Jun Zhang, Yue Zhang

  • September 14, 2026

Related Content

Retraction Note: TWIST1 activates cancer stem cell marker genes to promote epithelial‑mesenchymal transition and tumorigenesis in esophageal squamous cell carcinoma

Cost-Effectiveness of Electronic Patient-Reported Outcome Measure Interventions in Cancer: Systematic Review and Parameter Extraction for Economic Modeling

The impact of prevalent primary cancers in melanoma patients on survival